埋め込み型神経調節装置の世界市場見通し2022年-2028年

◆英語タイトル:Implantable Neuromodulation Device Market, Global Outlook and Forecast 2022-2028

Market Monitor Globalが発行した調査報告書(MMG22NV11405)◆商品コード:MMG22NV11405
◆発行会社(リサーチ会社):Market Monitor Global
◆発行日:2022年11月
◆ページ数:72
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2-3営業日)
◆調査対象地域:グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,250 ⇒換算¥481,000見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD4,225 ⇒換算¥625,300見積依頼/購入/質問フォーム
Enterprise User(閲覧人数制限なし)USD4,875 ⇒換算¥721,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の埋め込み型神経調節装置市場規模と予測を収録しています。・世界の埋め込み型神経調節装置市場:売上、2017年-2022年、2023年-2028年
・世界の埋め込み型神経調節装置市場:販売量、2017年-2022年、2023年-2028年
・世界のトップ5企業、2021年

世界の埋め込み型神経調節装置市場は2021年に000Mドルと評価され、予測期間中に000%のCAGRで2028年までに000Mドルに達すると予測されています。米国市場は2021年に000Mドルと推定されており、中国は2028年までに000Mドルに達すると予測されています。「脊髄刺激」セグメントは今後6年間、000%のCAGRで2028年までに000Mドルに成長すると予測されています。

埋め込み型神経調節装置のグローバル主要企業は、Medtronic、 Abbott、 Boston Scientific Corporation、 St. Jude Medical、 Synapse Biomedical、 Nevro Corporation、 Neuropace、 Cyberonics、 Autonomic Technologies、 Avery Biomedical、 Greatbatch Medicalなどです。2021年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL(MMG)は、埋め込み型神経調節装置のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の埋め込み型神経調節装置市場:タイプ別、2017年-2022年、2023年-2028年
世界の埋め込み型神経調節装置市場:タイプ別市場シェア、2021年
・脊髄刺激、脳深部刺激、胃刺激、経頭蓋磁気刺激、経皮電気刺激、その他

世界の埋め込み型神経調節装置市場:用途別、2017年-2022年、2023年-2028年
世界の埋め込み型神経調節装置市場:用途別市場シェア、2021年
・パーキンソン病、てんかん、痛み、その他

世界の埋め込み型神経調節装置市場:地域・国別、2017年-2022年、2023年-2028年
世界の埋め込み型神経調節装置市場:地域別市場シェア、2021年
・北米:アメリカ、カナダ、メキシコ
・ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
・アジア:中国、日本、韓国、東南アジア、インド
・南米:ブラジル、アルゼンチン
・中東・アフリカ:トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における埋め込み型神経調節装置のグローバル売上、2017年-2022年
・主要企業における埋め込み型神経調節装置のグローバル売上シェア、2021年
・主要企業における埋め込み型神経調節装置のグローバル販売量、2017年-2022年
・主要企業における埋め込み型神経調節装置のグローバル販売量シェア、2021年

さらに、当レポートは主要企業のプロファイルを提示します。
Medtronic、 Abbott、 Boston Scientific Corporation、 St. Jude Medical、 Synapse Biomedical、 Nevro Corporation、 Neuropace、 Cyberonics、 Autonomic Technologies、 Avery Biomedical、 Greatbatch Medical

*************************************************************

・調査・分析レポートの概要
埋め込み型神経調節装置市場の定義
市場セグメント
世界の埋め込み型神経調節装置市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の埋め込み型神経調節装置市場規模
世界の埋め込み型神経調節装置市場規模:2021年 VS 2028年
世界の埋め込み型神経調節装置市場規模と予測 2017年-2028年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの埋め込み型神経調節装置の売上
グローバルトップ3およびトップ5企業、2021年売上ベース
グローバル企業の埋め込み型神経調節装置製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分:脊髄刺激、脳深部刺激、胃刺激、経頭蓋磁気刺激、経皮電気刺激、その他
埋め込み型神経調節装置のタイプ別グローバル売上・予測

・用途別市場分析
用途区分:パーキンソン病、てんかん、痛み、その他
埋め込み型神経調節装置の用途別グローバル売上・予測

・地域別市場分析
地域別埋め込み型神経調節装置市場規模 2021年と2028年
地域別埋め込み型神経調節装置売上・予測
北米市場:アメリカ、カナダ、メキシコ
ヨーロッパ市場:ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場:中国、日本、韓国、東南アジア、インド
南米市場:ブラジル、アルゼンチン
中東・アフリカ市場:トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル(企業概要、事業概要、主要製品、売上、ニュースなど)
Medtronic、 Abbott、 Boston Scientific Corporation、 St. Jude Medical、 Synapse Biomedical、 Nevro Corporation、 Neuropace、 Cyberonics、 Autonomic Technologies、 Avery Biomedical、 Greatbatch Medical
...

Neuromodulation devices are advanced medical tools that can increase or decrease the activity of the nervous system. Research has found this technology may be effective in reducing migraine attacks and cluster headaches.
This report contains market size and forecasts of Implantable Neuromodulation Device in global, including the following market information:
Global Implantable Neuromodulation Device Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Implantable Neuromodulation Device Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Implantable Neuromodulation Device companies in 2021 (%)
The global Implantable Neuromodulation Device market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Spinal Cord Stimulation Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Implantable Neuromodulation Device include Medtronic, Abbott, Boston Scientific Corporation, St. Jude Medical, Synapse Biomedical, Nevro Corporation, Neuropace, Cyberonics and Autonomic Technologies, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Implantable Neuromodulation Device manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Implantable Neuromodulation Device Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Implantable Neuromodulation Device Market Segment Percentages, by Type, 2021 (%)
Spinal Cord Stimulation
Deep Brain Stimulation
Gastric Stimulation
Transcranial Magnetic Stimulation
Transcutaneous Electrical Stimulation
Other
Global Implantable Neuromodulation Device Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Implantable Neuromodulation Device Market Segment Percentages, by Application, 2021 (%)
Parkinson’s Disease
Epilepsy
Pain
Other
Global Implantable Neuromodulation Device Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Implantable Neuromodulation Device Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Implantable Neuromodulation Device revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Implantable Neuromodulation Device revenues share in global market, 2021 (%)
Key companies Implantable Neuromodulation Device sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Implantable Neuromodulation Device sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Medtronic
Abbott
Boston Scientific Corporation
St. Jude Medical
Synapse Biomedical
Nevro Corporation
Neuropace
Cyberonics
Autonomic Technologies
Avery Biomedical
Greatbatch Medical

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Implantable Neuromodulation Device Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Implantable Neuromodulation Device Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Implantable Neuromodulation Device Overall Market Size
2.1 Global Implantable Neuromodulation Device Market Size: 2021 VS 2028
2.2 Global Implantable Neuromodulation Device Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Implantable Neuromodulation Device Sales: 2017-2028
3 Company Landscape
3.1 Top Implantable Neuromodulation Device Players in Global Market
3.2 Top Global Implantable Neuromodulation Device Companies Ranked by Revenue
3.3 Global Implantable Neuromodulation Device Revenue by Companies
3.4 Global Implantable Neuromodulation Device Sales by Companies
3.5 Global Implantable Neuromodulation Device Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Implantable Neuromodulation Device Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Implantable Neuromodulation Device Product Type
3.8 Tier 1, Tier 2 and Tier 3 Implantable Neuromodulation Device Players in Global Market
3.8.1 List of Global Tier 1 Implantable Neuromodulation Device Companies
3.8.2 List of Global Tier 2 and Tier 3 Implantable Neuromodulation Device Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Implantable Neuromodulation Device Market Size Markets, 2021 & 2028
4.1.2 Spinal Cord Stimulation
4.1.3 Deep Brain Stimulation
4.1.4 Gastric Stimulation
4.1.5 Transcranial Magnetic Stimulation
4.1.6 Transcutaneous Electrical Stimulation
4.1.7 Other
4.2 By Type – Global Implantable Neuromodulation Device Revenue & Forecasts
4.2.1 By Type – Global Implantable Neuromodulation Device Revenue, 2017-2022
4.2.2 By Type – Global Implantable Neuromodulation Device Revenue, 2023-2028
4.2.3 By Type – Global Implantable Neuromodulation Device Revenue Market Share, 2017-2028
4.3 By Type – Global Implantable Neuromodulation Device Sales & Forecasts
4.3.1 By Type – Global Implantable Neuromodulation Device Sales, 2017-2022
4.3.2 By Type – Global Implantable Neuromodulation Device Sales, 2023-2028
4.3.3 By Type – Global Implantable Neuromodulation Device Sales Market Share, 2017-2028
4.4 By Type – Global Implantable Neuromodulation Device Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application – Global Implantable Neuromodulation Device Market Size, 2021 & 2028
5.1.2 Parkinson’s Disease
5.1.3 Epilepsy
5.1.4 Pain
5.1.5 Other
5.2 By Application – Global Implantable Neuromodulation Device Revenue & Forecasts
5.2.1 By Application – Global Implantable Neuromodulation Device Revenue, 2017-2022
5.2.2 By Application – Global Implantable Neuromodulation Device Revenue, 2023-2028
5.2.3 By Application – Global Implantable Neuromodulation Device Revenue Market Share, 2017-2028
5.3 By Application – Global Implantable Neuromodulation Device Sales & Forecasts
5.3.1 By Application – Global Implantable Neuromodulation Device Sales, 2017-2022
5.3.2 By Application – Global Implantable Neuromodulation Device Sales, 2023-2028
5.3.3 By Application – Global Implantable Neuromodulation Device Sales Market Share, 2017-2028
5.4 By Application – Global Implantable Neuromodulation Device Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region – Global Implantable Neuromodulation Device Market Size, 2021 & 2028
6.2 By Region – Global Implantable Neuromodulation Device Revenue & Forecasts
6.2.1 By Region – Global Implantable Neuromodulation Device Revenue, 2017-2022
6.2.2 By Region – Global Implantable Neuromodulation Device Revenue, 2023-2028
6.2.3 By Region – Global Implantable Neuromodulation Device Revenue Market Share, 2017-2028
6.3 By Region – Global Implantable Neuromodulation Device Sales & Forecasts
6.3.1 By Region – Global Implantable Neuromodulation Device Sales, 2017-2022
6.3.2 By Region – Global Implantable Neuromodulation Device Sales, 2023-2028
6.3.3 By Region – Global Implantable Neuromodulation Device Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country – North America Implantable Neuromodulation Device Revenue, 2017-2028
6.4.2 By Country – North America Implantable Neuromodulation Device Sales, 2017-2028
6.4.3 US Implantable Neuromodulation Device Market Size, 2017-2028
6.4.4 Canada Implantable Neuromodulation Device Market Size, 2017-2028
6.4.5 Mexico Implantable Neuromodulation Device Market Size, 2017-2028
6.5 Europe
6.5.1 By Country – Europe Implantable Neuromodulation Device Revenue, 2017-2028
6.5.2 By Country – Europe Implantable Neuromodulation Device Sales, 2017-2028
6.5.3 Germany Implantable Neuromodulation Device Market Size, 2017-2028
6.5.4 France Implantable Neuromodulation Device Market Size, 2017-2028
6.5.5 U.K. Implantable Neuromodulation Device Market Size, 2017-2028
6.5.6 Italy Implantable Neuromodulation Device Market Size, 2017-2028
6.5.7 Russia Implantable Neuromodulation Device Market Size, 2017-2028
6.5.8 Nordic Countries Implantable Neuromodulation Device Market Size, 2017-2028
6.5.9 Benelux Implantable Neuromodulation Device Market Size, 2017-2028
6.6 Asia
6.6.1 By Region – Asia Implantable Neuromodulation Device Revenue, 2017-2028
6.6.2 By Region – Asia Implantable Neuromodulation Device Sales, 2017-2028
6.6.3 China Implantable Neuromodulation Device Market Size, 2017-2028
6.6.4 Japan Implantable Neuromodulation Device Market Size, 2017-2028
6.6.5 South Korea Implantable Neuromodulation Device Market Size, 2017-2028
6.6.6 Southeast Asia Implantable Neuromodulation Device Market Size, 2017-2028
6.6.7 India Implantable Neuromodulation Device Market Size, 2017-2028
6.7 South America
6.7.1 By Country – South America Implantable Neuromodulation Device Revenue, 2017-2028
6.7.2 By Country – South America Implantable Neuromodulation Device Sales, 2017-2028
6.7.3 Brazil Implantable Neuromodulation Device Market Size, 2017-2028
6.7.4 Argentina Implantable Neuromodulation Device Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Implantable Neuromodulation Device Revenue, 2017-2028
6.8.2 By Country – Middle East & Africa Implantable Neuromodulation Device Sales, 2017-2028
6.8.3 Turkey Implantable Neuromodulation Device Market Size, 2017-2028
6.8.4 Israel Implantable Neuromodulation Device Market Size, 2017-2028
6.8.5 Saudi Arabia Implantable Neuromodulation Device Market Size, 2017-2028
6.8.6 UAE Implantable Neuromodulation Device Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Medtronic
7.1.1 Medtronic Corporate Summary
7.1.2 Medtronic Business Overview
7.1.3 Medtronic Implantable Neuromodulation Device Major Product Offerings
7.1.4 Medtronic Implantable Neuromodulation Device Sales and Revenue in Global (2017-2022)
7.1.5 Medtronic Key News
7.2 Abbott
7.2.1 Abbott Corporate Summary
7.2.2 Abbott Business Overview
7.2.3 Abbott Implantable Neuromodulation Device Major Product Offerings
7.2.4 Abbott Implantable Neuromodulation Device Sales and Revenue in Global (2017-2022)
7.2.5 Abbott Key News
7.3 Boston Scientific Corporation
7.3.1 Boston Scientific Corporation Corporate Summary
7.3.2 Boston Scientific Corporation Business Overview
7.3.3 Boston Scientific Corporation Implantable Neuromodulation Device Major Product Offerings
7.3.4 Boston Scientific Corporation Implantable Neuromodulation Device Sales and Revenue in Global (2017-2022)
7.3.5 Boston Scientific Corporation Key News
7.4 St. Jude Medical
7.4.1 St. Jude Medical Corporate Summary
7.4.2 St. Jude Medical Business Overview
7.4.3 St. Jude Medical Implantable Neuromodulation Device Major Product Offerings
7.4.4 St. Jude Medical Implantable Neuromodulation Device Sales and Revenue in Global (2017-2022)
7.4.5 St. Jude Medical Key News
7.5 Synapse Biomedical
7.5.1 Synapse Biomedical Corporate Summary
7.5.2 Synapse Biomedical Business Overview
7.5.3 Synapse Biomedical Implantable Neuromodulation Device Major Product Offerings
7.5.4 Synapse Biomedical Implantable Neuromodulation Device Sales and Revenue in Global (2017-2022)
7.5.5 Synapse Biomedical Key News
7.6 Nevro Corporation
7.6.1 Nevro Corporation Corporate Summary
7.6.2 Nevro Corporation Business Overview
7.6.3 Nevro Corporation Implantable Neuromodulation Device Major Product Offerings
7.6.4 Nevro Corporation Implantable Neuromodulation Device Sales and Revenue in Global (2017-2022)
7.6.5 Nevro Corporation Key News
7.7 Neuropace
7.7.1 Neuropace Corporate Summary
7.7.2 Neuropace Business Overview
7.7.3 Neuropace Implantable Neuromodulation Device Major Product Offerings
7.7.4 Neuropace Implantable Neuromodulation Device Sales and Revenue in Global (2017-2022)
7.7.5 Neuropace Key News
7.8 Cyberonics
7.8.1 Cyberonics Corporate Summary
7.8.2 Cyberonics Business Overview
7.8.3 Cyberonics Implantable Neuromodulation Device Major Product Offerings
7.8.4 Cyberonics Implantable Neuromodulation Device Sales and Revenue in Global (2017-2022)
7.8.5 Cyberonics Key News
7.9 Autonomic Technologies
7.9.1 Autonomic Technologies Corporate Summary
7.9.2 Autonomic Technologies Business Overview
7.9.3 Autonomic Technologies Implantable Neuromodulation Device Major Product Offerings
7.9.4 Autonomic Technologies Implantable Neuromodulation Device Sales and Revenue in Global (2017-2022)
7.9.5 Autonomic Technologies Key News
7.10 Avery Biomedical
7.10.1 Avery Biomedical Corporate Summary
7.10.2 Avery Biomedical Business Overview
7.10.3 Avery Biomedical Implantable Neuromodulation Device Major Product Offerings
7.10.4 Avery Biomedical Implantable Neuromodulation Device Sales and Revenue in Global (2017-2022)
7.10.5 Avery Biomedical Key News
7.11 Greatbatch Medical
7.11.1 Greatbatch Medical Corporate Summary
7.11.2 Greatbatch Medical Implantable Neuromodulation Device Business Overview
7.11.3 Greatbatch Medical Implantable Neuromodulation Device Major Product Offerings
7.11.4 Greatbatch Medical Implantable Neuromodulation Device Sales and Revenue in Global (2017-2022)
7.11.5 Greatbatch Medical Key News
8 Global Implantable Neuromodulation Device Production Capacity, Analysis
8.1 Global Implantable Neuromodulation Device Production Capacity, 2017-2028
8.2 Implantable Neuromodulation Device Production Capacity of Key Manufacturers in Global Market
8.3 Global Implantable Neuromodulation Device Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Implantable Neuromodulation Device Supply Chain Analysis
10.1 Implantable Neuromodulation Device Industry Value Chain
10.2 Implantable Neuromodulation Device Upstream Market
10.3 Implantable Neuromodulation Device Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Implantable Neuromodulation Device Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Implantable Neuromodulation Device in Global Market
Table 2. Top Implantable Neuromodulation Device Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Implantable Neuromodulation Device Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Implantable Neuromodulation Device Revenue Share by Companies, 2017-2022
Table 5. Global Implantable Neuromodulation Device Sales by Companies, (K Units), 2017-2022
Table 6. Global Implantable Neuromodulation Device Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Implantable Neuromodulation Device Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Implantable Neuromodulation Device Product Type
Table 9. List of Global Tier 1 Implantable Neuromodulation Device Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Implantable Neuromodulation Device Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Implantable Neuromodulation Device Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Implantable Neuromodulation Device Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Implantable Neuromodulation Device Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Implantable Neuromodulation Device Sales (K Units), 2017-2022
Table 15. By Type - Global Implantable Neuromodulation Device Sales (K Units), 2023-2028
Table 16. By Application – Global Implantable Neuromodulation Device Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Implantable Neuromodulation Device Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Implantable Neuromodulation Device Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Implantable Neuromodulation Device Sales (K Units), 2017-2022
Table 20. By Application - Global Implantable Neuromodulation Device Sales (K Units), 2023-2028
Table 21. By Region – Global Implantable Neuromodulation Device Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Implantable Neuromodulation Device Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Implantable Neuromodulation Device Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Implantable Neuromodulation Device Sales (K Units), 2017-2022
Table 25. By Region - Global Implantable Neuromodulation Device Sales (K Units), 2023-2028
Table 26. By Country - North America Implantable Neuromodulation Device Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Implantable Neuromodulation Device Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Implantable Neuromodulation Device Sales, (K Units), 2017-2022
Table 29. By Country - North America Implantable Neuromodulation Device Sales, (K Units), 2023-2028
Table 30. By Country - Europe Implantable Neuromodulation Device Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Implantable Neuromodulation Device Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Implantable Neuromodulation Device Sales, (K Units), 2017-2022
Table 33. By Country - Europe Implantable Neuromodulation Device Sales, (K Units), 2023-2028
Table 34. By Region - Asia Implantable Neuromodulation Device Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Implantable Neuromodulation Device Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Implantable Neuromodulation Device Sales, (K Units), 2017-2022
Table 37. By Region - Asia Implantable Neuromodulation Device Sales, (K Units), 2023-2028
Table 38. By Country - South America Implantable Neuromodulation Device Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Implantable Neuromodulation Device Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Implantable Neuromodulation Device Sales, (K Units), 2017-2022
Table 41. By Country - South America Implantable Neuromodulation Device Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Implantable Neuromodulation Device Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Implantable Neuromodulation Device Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Implantable Neuromodulation Device Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Implantable Neuromodulation Device Sales, (K Units), 2023-2028
Table 46. Medtronic Corporate Summary
Table 47. Medtronic Implantable Neuromodulation Device Product Offerings
Table 48. Medtronic Implantable Neuromodulation Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Abbott Corporate Summary
Table 50. Abbott Implantable Neuromodulation Device Product Offerings
Table 51. Abbott Implantable Neuromodulation Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Boston Scientific Corporation Corporate Summary
Table 53. Boston Scientific Corporation Implantable Neuromodulation Device Product Offerings
Table 54. Boston Scientific Corporation Implantable Neuromodulation Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. St. Jude Medical Corporate Summary
Table 56. St. Jude Medical Implantable Neuromodulation Device Product Offerings
Table 57. St. Jude Medical Implantable Neuromodulation Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Synapse Biomedical Corporate Summary
Table 59. Synapse Biomedical Implantable Neuromodulation Device Product Offerings
Table 60. Synapse Biomedical Implantable Neuromodulation Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Nevro Corporation Corporate Summary
Table 62. Nevro Corporation Implantable Neuromodulation Device Product Offerings
Table 63. Nevro Corporation Implantable Neuromodulation Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Neuropace Corporate Summary
Table 65. Neuropace Implantable Neuromodulation Device Product Offerings
Table 66. Neuropace Implantable Neuromodulation Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Cyberonics Corporate Summary
Table 68. Cyberonics Implantable Neuromodulation Device Product Offerings
Table 69. Cyberonics Implantable Neuromodulation Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Autonomic Technologies Corporate Summary
Table 71. Autonomic Technologies Implantable Neuromodulation Device Product Offerings
Table 72. Autonomic Technologies Implantable Neuromodulation Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Avery Biomedical Corporate Summary
Table 74. Avery Biomedical Implantable Neuromodulation Device Product Offerings
Table 75. Avery Biomedical Implantable Neuromodulation Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Greatbatch Medical Corporate Summary
Table 77. Greatbatch Medical Implantable Neuromodulation Device Product Offerings
Table 78. Greatbatch Medical Implantable Neuromodulation Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. Implantable Neuromodulation Device Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 80. Global Implantable Neuromodulation Device Capacity Market Share of Key Manufacturers, 2020-2022
Table 81. Global Implantable Neuromodulation Device Production by Region, 2017-2022 (K Units)
Table 82. Global Implantable Neuromodulation Device Production by Region, 2023-2028 (K Units)
Table 83. Implantable Neuromodulation Device Market Opportunities & Trends in Global Market
Table 84. Implantable Neuromodulation Device Market Drivers in Global Market
Table 85. Implantable Neuromodulation Device Market Restraints in Global Market
Table 86. Implantable Neuromodulation Device Raw Materials
Table 87. Implantable Neuromodulation Device Raw Materials Suppliers in Global Market
Table 88. Typical Implantable Neuromodulation Device Downstream
Table 89. Implantable Neuromodulation Device Downstream Clients in Global Market
Table 90. Implantable Neuromodulation Device Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Implantable Neuromodulation Device Segment by Type
Figure 2. Implantable Neuromodulation Device Segment by Application
Figure 3. Global Implantable Neuromodulation Device Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Implantable Neuromodulation Device Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Implantable Neuromodulation Device Revenue, 2017-2028 (US$, Mn)
Figure 7. Implantable Neuromodulation Device Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Implantable Neuromodulation Device Revenue in 2021
Figure 9. By Type - Global Implantable Neuromodulation Device Sales Market Share, 2017-2028
Figure 10. By Type - Global Implantable Neuromodulation Device Revenue Market Share, 2017-2028
Figure 11. By Type - Global Implantable Neuromodulation Device Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Implantable Neuromodulation Device Sales Market Share, 2017-2028
Figure 13. By Application - Global Implantable Neuromodulation Device Revenue Market Share, 2017-2028
Figure 14. By Application - Global Implantable Neuromodulation Device Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Implantable Neuromodulation Device Sales Market Share, 2017-2028
Figure 16. By Region - Global Implantable Neuromodulation Device Revenue Market Share, 2017-2028
Figure 17. By Country - North America Implantable Neuromodulation Device Revenue Market Share, 2017-2028
Figure 18. By Country - North America Implantable Neuromodulation Device Sales Market Share, 2017-2028
Figure 19. US Implantable Neuromodulation Device Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Implantable Neuromodulation Device Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Implantable Neuromodulation Device Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Implantable Neuromodulation Device Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Implantable Neuromodulation Device Sales Market Share, 2017-2028
Figure 24. Germany Implantable Neuromodulation Device Revenue, (US$, Mn), 2017-2028
Figure 25. France Implantable Neuromodulation Device Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Implantable Neuromodulation Device Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Implantable Neuromodulation Device Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Implantable Neuromodulation Device Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Implantable Neuromodulation Device Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Implantable Neuromodulation Device Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Implantable Neuromodulation Device Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Implantable Neuromodulation Device Sales Market Share, 2017-2028
Figure 33. China Implantable Neuromodulation Device Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Implantable Neuromodulation Device Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Implantable Neuromodulation Device Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Implantable Neuromodulation Device Revenue, (US$, Mn), 2017-2028
Figure 37. India Implantable Neuromodulation Device Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Implantable Neuromodulation Device Revenue Market Share, 2017-2028
Figure 39. By Country - South America Implantable Neuromodulation Device Sales Market Share, 2017-2028
Figure 40. Brazil Implantable Neuromodulation Device Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Implantable Neuromodulation Device Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Implantable Neuromodulation Device Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Implantable Neuromodulation Device Sales Market Share, 2017-2028
Figure 44. Turkey Implantable Neuromodulation Device Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Implantable Neuromodulation Device Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Implantable Neuromodulation Device Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Implantable Neuromodulation Device Revenue, (US$, Mn), 2017-2028
Figure 48. Global Implantable Neuromodulation Device Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Implantable Neuromodulation Device by Region, 2021 VS 2028
Figure 50. Implantable Neuromodulation Device Industry Value Chain
Figure 51. Marketing Channels


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 埋め込み型神経調節装置の世界市場見通し2022年-2028年(Implantable Neuromodulation Device Market, Global Outlook and Forecast 2022-2028)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆